Pasithea Therapeutics Corp. ( KTTA) - Key Metrics
KTTA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$164.29 | -$295.64 | -$295.64 |
| 2026Q1 | $0 | -$0.41 | -$0.68 | -$0.68 |
| 2025Q4 | $0 | -$1.44 | -$0.77 | -$0.77 |
| 2025Q3 | $0 | -$0.41 | -$0.39 | -$0.39 |
| 2025Q2 | $0 | -$0.66 | -$0.69 | -$0.69 |
KTTA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.81 |
| 2026Q1 | 0% | -0.45 |
| 2025Q4 | 0% | -0.36 |
| 2025Q3 | 0% | -0.45 |
| 2025Q2 | 0% | -0.27 |
KTTA
Price: $0.50
52 week price:
Earnings Per Share: -1.42 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 51500
Market Capitalization: 16.1 million